{"id":"levothyroxine-tablet","safety":{"commonSideEffects":[{"rate":null,"effect":"Tachycardia"},{"rate":null,"effect":"Tremor"},{"rate":null,"effect":"Anxiety"},{"rate":null,"effect":"Insomnia"},{"rate":null,"effect":"Heat intolerance"},{"rate":null,"effect":"Palpitations"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Levothyroxine (T4) is converted peripherally to the active form triiodothyronine (T3), which binds to thyroid hormone receptors in target tissues to regulate metabolism, growth, and development. It is used to treat hypothyroidism by restoring circulating thyroid hormone levels to normal physiological ranges, thereby normalizing metabolic rate and alleviating symptoms of thyroid hormone deficiency.","oneSentence":"Levothyroxine is a synthetic thyroid hormone that replaces or supplements endogenous thyroid hormone to restore normal metabolic function.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:52:04.764Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypothyroidism"},{"name":"Thyroid cancer suppression therapy"},{"name":"Myxedema coma"}]},"trialDetails":[{"nctId":"NCT07424183","phase":"PHASE2","title":"T4/T3 Therapy in Hypothyroidism","status":"NOT_YET_RECRUITING","sponsor":"University of Pennsylvania","startDate":"2026-03","conditions":"Hypothyroidism Primary","enrollment":60},{"nctId":"NCT05526144","phase":"PHASE2","title":"Thyroid Hormone for Treatment of Nonalcoholic Steatohepatitis in Veterans","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2023-04-01","conditions":"Nonalcoholic Steatohepatitis, Liver Fibrosis","enrollment":128},{"nctId":"NCT06647602","phase":"","title":"Thyroid Hormone Replacement After Radio Iodine: Value and Efficacy","status":"NOT_YET_RECRUITING","sponsor":"University Medical Center Groningen","startDate":"2026-09-01","conditions":"Differentiated Thyroid Cancer, Thyroid Cancer, Levothyroxine","enrollment":40},{"nctId":"NCT06790589","phase":"PHASE2","title":"COACH - Comparing Two Different Methods to Suppress Thyrotropin in Patients With Advanced Thyroid Cancer","status":"NOT_YET_RECRUITING","sponsor":"AHS Cancer Control Alberta","startDate":"2026-12","conditions":"Advanced Differentiated Thyroid Gland Carcinoma","enrollment":70},{"nctId":"NCT01391962","phase":"PHASE2","title":"Sunitinib or Cediranib for Alveolar Soft Part Sarcoma","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2011-07-18","conditions":"Sarcoma, Alveolar Soft Part","enrollment":34},{"nctId":"NCT07332273","phase":"PHASE3","title":"Levothyroxine as Adjuvant to a Hypocaloric Diet for the Treatment of Obesity.","status":"RECRUITING","sponsor":"Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud","startDate":"2025-11-05","conditions":"Obesity","enrollment":286},{"nctId":"NCT06345339","phase":"PHASE2, PHASE3","title":"A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants","status":"RECRUITING","sponsor":"AbbVie","startDate":"2024-04-26","conditions":"Hypothyroidism","enrollment":2800},{"nctId":"NCT05228184","phase":"PHASE4","title":"Use of Tirosint®-SOL or Tablet Formulations of Levothyroxine in Pediatric Patients With Congenital Hypothyroidism (CH)","status":"TERMINATED","sponsor":"IBSA Institut Biochimique SA","startDate":"2022-01-21","conditions":"Congenital Hypothyroidism","enrollment":34},{"nctId":"NCT06652113","phase":"NA","title":"Effect of HCQ Combined With LT4 on LBR in Euthyroid Women With URPL and TPO-Ab","status":"RECRUITING","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2024-11-15","conditions":"Recurrent Pregnancy Loss, Euthyroid With Thyroid Antibodies","enrollment":796},{"nctId":"NCT06041204","phase":"NA","title":"Best Treatment for Women With Both (Polycystic Ovary Syndrome) PCOS and Subclinical Hypothyroidism","status":"RECRUITING","sponsor":"Muhamed Ahmed Abdelmoaty Muhamed Alhagrasy","startDate":"2021-05-06","conditions":"PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries, Subclinical Hypothyroidism, Female Infertility","enrollment":200},{"nctId":"NCT06660823","phase":"PHASE3","title":"Role of Levothyroxine Supplementation in Delayed Recovery Following Cardiac Surgery","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2024-11-30","conditions":"Cardiac Surgery Intensive Care Treatment, Delayed Recovery From Anaesthesia, Euthyroid Sick Syndrome","enrollment":70},{"nctId":"NCT07011953","phase":"EARLY_PHASE1","title":"A Clinical Trial of Adjunctive Thyroxine for Avolition in Schizophrenia","status":"NOT_YET_RECRUITING","sponsor":"Peking University","startDate":"2025-07-01","conditions":"Schizophrenia, Avolition","enrollment":90},{"nctId":"NCT06999278","phase":"PHASE3","title":"LIGHT Trial: Levothyroxine for Gestational Hypothyroidism in Recurrent Pregnancy Loss","status":"NOT_YET_RECRUITING","sponsor":"Women's Hospital School Of Medicine Zhejiang University","startDate":"2025-06-01","conditions":"Abortion, Habitual","enrollment":200},{"nctId":"NCT05682482","phase":"PHASE3","title":"LT4/LT3 Combination Therapy Versus LT4 Monotherapy in Patients with Autoimmune Hypothyroidism.","status":"RECRUITING","sponsor":"M. Medici","startDate":"2022-10-07","conditions":"Autoimmune Hypothyroidism","enrollment":600},{"nctId":"NCT04111536","phase":"PHASE1, PHASE2","title":"Developing Oral LT3 Therapy for Heart Failure - HFpEF","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2020-03-08","conditions":"Heart Failure With Preserved Ejection Fraction, Low Triiodothyronine Syndrome","enrollment":28},{"nctId":"NCT04112316","phase":"PHASE1, PHASE2","title":"Developing Oral LT3 Therapy for Heart Failure - HFrEF","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2020-02-11","conditions":"Heart Failure With Reduced Ejection Fraction (HFrEF), Low T3 Syndrome","enrollment":28},{"nctId":"NCT06653907","phase":"PHASE4","title":"Levothyroxine Intervention in Pregnant Women with TSH （2.5 MIU/L-upper Limit of Reference Range） and Negative Thyroid Peroxidase Antibody","status":"NOT_YET_RECRUITING","sponsor":"Yang ZHANG","startDate":"2024-10-25","conditions":"Thyroid Abnormalities, Pregnant Woman, Pregnancy Outcomes","enrollment":400},{"nctId":"NCT06547242","phase":"PHASE1","title":"Levothyroxine-sodium Bioequivalence Trial With Oral Single Dose Administration","status":"COMPLETED","sponsor":"Berlin-Chemie AG Menarini Group","startDate":"2021-10-22","conditions":"Healthy","enrollment":132},{"nctId":"NCT06373523","phase":"EARLY_PHASE1","title":"MASLD in Primary Hypothyroidism and Efficacy of Dapaglifozin","status":"NOT_YET_RECRUITING","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2024-09-01","conditions":"Hepatic Steato-Fibrosis, Non-Alcoholic Fatty Liver Disease","enrollment":60},{"nctId":"NCT04782856","phase":"PHASE2","title":"Energy Metabolism in Thyroidectomized Patients","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2020-10-28","conditions":"Thyroid Goiter, Hypothyroidism, Thyroid Cancer","enrollment":13},{"nctId":"NCT00648557","phase":"PHASE1","title":"Fasting Study of Levothyroxine Sodium Tablets 200 mg to Synthroid Tablets 200 mg","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2003-01","conditions":"Healthy","enrollment":32},{"nctId":"NCT00648700","phase":"PHASE1","title":"Fasting Study of Levothyroxine Sodium Tablets 300 μg to Levothroid® Tablets 300 μg","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2005-08","conditions":"Healthy","enrollment":32},{"nctId":"NCT00648882","phase":"PHASE1","title":"Fasting Study of Levothyroxine Sodium Tablets 300 mcg to Synthroid® Tablets 300 mcg","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2007-03","conditions":"Healthy","enrollment":33},{"nctId":"NCT00647855","phase":"PHASE1","title":"Fasting Study of Levothyroxine Sodium Tablets 300 μg to Synthroid® Tablets 300 μg","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2003-05","conditions":"Healthy","enrollment":30},{"nctId":"NCT06353555","phase":"NA","title":"Efficacy of Thyroid Hormone Replacement for Secondary Hypothyroidism Following Intracerebral Hemorrhage","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2023-10-11","conditions":"Intracerebral Hemorrhage, Low T3 Syndrome, Neurocritical Care","enrollment":100},{"nctId":"NCT05733078","phase":"PHASE2","title":"Effect of Vitamin C Supplementation in Patients With Primary Hypothyroidism","status":"UNKNOWN","sponsor":"Dr Adnan Agha","startDate":"2023-11-01","conditions":"Hypothyroidism, Primary Hypothyroidism, Vitamin C Deficiency","enrollment":40},{"nctId":"NCT05461820","phase":"PHASE4","title":"Effects of Different Treatment Schemes on the Regulation and Recurrence of Graves' Disease","status":"RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2018-05-01","conditions":"Graves Disease, Relapse, Treatment","enrollment":240},{"nctId":"NCT04288115","phase":"PHASE4","title":"Discontinuation of Levothyroxine Therapy for Patients With Subclinical Hypothyroidism","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2021-03-24","conditions":"Subclinical Hypothyroidism","enrollment":52},{"nctId":"NCT06036576","phase":"PHASE3","title":"Thyroxine Therapy for Recurrent Pregnancy Loss in Hypothyroid Women","status":"COMPLETED","sponsor":"Al-Kindy College of Medicine","startDate":"2022-03-01","conditions":"Recurrent Early Pregnancy Loss, Thyroid Diseases","enrollment":77},{"nctId":"NCT04747275","phase":"PHASE4","title":"Use of Liquid Stable Levothyroxine in Trisomy 21 Pediatric Patients","status":"TERMINATED","sponsor":"Children's Mercy Hospital Kansas City","startDate":"2021-01-18","conditions":"Hypothyroidism, Trisomy 21","enrollment":6},{"nctId":"NCT04878614","phase":"PHASE4","title":"Comparison of Levothyroxine Formulation in Hypothyroid Patients With Enteral Feeding","status":"TERMINATED","sponsor":"University of California, Los Angeles","startDate":"2021-05-05","conditions":"Hypothyroidism","enrollment":3},{"nctId":"NCT05804149","phase":"PHASE2","title":"Effect of Acupuncture and Low Caloric Diet on Primary Hypothyroidism and Irregular Menstruation in Infertile Women","status":"COMPLETED","sponsor":"Cairo University","startDate":"2020-08-30","conditions":"Primary Hypothyroidism, Acupuncture, Irregular Menstruation","enrollment":60},{"nctId":"NCT05803967","phase":"NA","title":"Baduanjin Exercising Effects on Sub-clinical Hypothyroidism and Cognitive Problems","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2022-12-18","conditions":"Subclinical hypothyroïdism, Cognitive Impairment","enrollment":40},{"nctId":"NCT01848171","phase":"PHASE4","title":"Effects of L-thyroxine Replacement on Serum Lipid and Atherosclerosis in Hypothyroidism","status":"UNKNOWN","sponsor":"Shandong Provincial Hospital","startDate":"2013-07","conditions":"Hypothyroidism, Thyroid Diseases, Endocrine System Diseases","enrollment":700},{"nctId":"NCT05174000","phase":"PHASE1","title":"BE of Euthyrox® Tablets (Merck Nantong Versus Merck Darmstadt Sites)","status":"COMPLETED","sponsor":"Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany","startDate":"2022-01-10","conditions":"Healthy","enrollment":56},{"nctId":"NCT03787303","phase":"PHASE2","title":"Study of Euthyroid Hypothyroxinemia in Metastatic Breast Carcinoma","status":"TERMINATED","sponsor":"Aultman Health Foundation","startDate":"2019-03-01","conditions":"Metastatic Breast Cancer, Thyroid Dysfunction","enrollment":7},{"nctId":"NCT05240911","phase":"NA","title":"Individual Dosing of Levothyroxine After Thyroidectomy","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2022-06-01","conditions":"Thyroid Neoplasms, Hypothyroidism, Surgery","enrollment":202},{"nctId":"NCT03094416","phase":"PHASE4","title":"Levothyroxine Sodium in Thyroidectomized Patients Taking Proton Pump Inhibitors","status":"COMPLETED","sponsor":"IBSA Institut Biochimique SA","startDate":"2018-07-30","conditions":"Hypothyroidism;Postablative","enrollment":66},{"nctId":"NCT05247476","phase":"PHASE4","title":"Type 2 Deiodinase Gene Polymorphism and the Treatment of Hypothyroidism Caused by Thyroidectomy in Thyroid Cancer Patients.","status":"UNKNOWN","sponsor":"Zhongshan Hospital Xiamen University","startDate":"2021-10-18","conditions":"Thyroid Cancer, Papillary, Hypothyroidism","enrollment":50},{"nctId":"NCT04412694","phase":"PHASE4","title":"The Effect of Preoperative Oral Dexamethasone Supplementation on the Outcome of Thyroidectomised Patients.","status":"UNKNOWN","sponsor":"Medical University of Lodz","startDate":"2020-07-01","conditions":"Hypocalcemia, Vitamin D Deficiency, Postoperative Complications","enrollment":100},{"nctId":"NCT04988802","phase":"NA","title":"The Effect of Dietary Supplements for Pregnant Women on Levothyroxine Absorption","status":"UNKNOWN","sponsor":"University Hospital Dubrava","startDate":"2021-10-20","conditions":"Hypothyroidism Primary","enrollment":37},{"nctId":"NCT04936698","phase":"","title":"The Prevalence and Risk Factors for Thyroid Dysfunction in Pregnant Women in Taiwan","status":"UNKNOWN","sponsor":"Chang Gung Memorial Hospital","startDate":"2021-07-16","conditions":"Thyroid Disease Pregnancy","enrollment":2000},{"nctId":"NCT04953195","phase":"PHASE4","title":"Thyroid Replacement Therapy in Patients With Subclinical Hypothyroidism","status":"UNKNOWN","sponsor":"Beijing Chao Yang Hospital","startDate":"2019-01-01","conditions":"Subclinical Hypothyroidisms","enrollment":30},{"nctId":"NCT03191188","phase":"NA","title":"A Pilot Feasibility Trial of Thyroid Hormone Replacement in Dialysis Patients","status":"UNKNOWN","sponsor":"University of California, Irvine","startDate":"2017-07-01","conditions":"Thyroid Disease, Kidney Diseases, Chronic","enrollment":96},{"nctId":"NCT03979274","phase":"PHASE1","title":"A Comparative Study of New Formulation and Approved Formulation for Levothyroxine in Healthy Volunteers","status":"COMPLETED","sponsor":"Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany","startDate":"2019-12-06","conditions":"Healthy","enrollment":44},{"nctId":"NCT02946918","phase":"PHASE4","title":"Levothyroxine Replacement With Liquid Gel Capsules vs Tablets Post-thyroidectomy","status":"TERMINATED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2017-02-01","conditions":"Thyroid Cancer, Postsurgical Hypothyroidism","enrollment":14},{"nctId":"NCT04619914","phase":"NA","title":"the Effect of Clomiphene Citrate Plus Estradiol Valerate Versus Letrozole on Endometrial Thickness and Pregnancy Rate in Infertile Women","status":"COMPLETED","sponsor":"Laylay Mohammed Khalleefah Alhibshi","startDate":"2019-03-01","conditions":"Endometrial Thickness, Pregnancy Rate","enrollment":160},{"nctId":"NCT01557504","phase":"PHASE1","title":"A Study to Assess the Pharmacokinetics and the Ability for Pediatric Participants With Type 2 Diabetes to Swallow MK-0431A XR Tablets (MK-0431A-296)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2012-07-18","conditions":"Type 2 Diabetes Mellitus","enrollment":25},{"nctId":"NCT04573907","phase":"PHASE4","title":"Bioequivalence Study of Levothyroxine Sodium Tablets 100 mcg","status":"COMPLETED","sponsor":"Tecnoquimicas","startDate":"2019-06-01","conditions":"Healthy","enrollment":80},{"nctId":"NCT04037748","phase":"PHASE1","title":"Bioequivalence of Two Formulations of Levothyroxine Sodium 200 Micrograms (mcg) Under Tablet Form","status":"COMPLETED","sponsor":"Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany","startDate":"2019-06-25","conditions":"Healthy","enrollment":72},{"nctId":"NCT01576705","phase":"PHASE3","title":"Efficacy Assessment of Systematic Treatment With Folinic Acid and Thyroid Hormone on Psychomotor Development of Down Syndrome Young Children","status":"COMPLETED","sponsor":"Institut Jerome Lejeune","startDate":"2012-04-02","conditions":"Down Syndrome","enrollment":175},{"nctId":"NCT04132622","phase":"PHASE4","title":"Low Dose Euthyrox in Treatments of Paraquat Intoxication.","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2020-01-01","conditions":"Paraquat Poisoning","enrollment":80},{"nctId":"NCT03856970","phase":"PHASE1","title":"Study to Evaluate the Effect of IW-3718 on the Pharmacokinetics of Oral Contraceptive, Levothyroxine, Glyburide, and Digoxin in Healthy Adult Volunteers","status":"COMPLETED","sponsor":"Ironwood Pharmaceuticals, Inc.","startDate":"2019-03-11","conditions":"Healthy Volunteers","enrollment":87},{"nctId":"NCT03898622","phase":"PHASE3","title":"Supplementation of Thyroid Hormone for TSH Control in Patients With Chronic Kidney Disease Without TRR.","status":"COMPLETED","sponsor":"Hospital Civil de Guadalajara","startDate":"2018-10-01","conditions":"Chronic Kidney Diseases, Subclinical Hypothyroidism","enrollment":32},{"nctId":"NCT03634371","phase":"PHASE4","title":"Bioequivalence Study of Levothyroxine Sodium Tablets 150 mcg","status":"UNKNOWN","sponsor":"Tecnoquimicas","startDate":"2018-08-10","conditions":"Healthy","enrollment":80},{"nctId":"NCT01465867","phase":"NA","title":"Selenium Supplementation in Pregnancy","status":"COMPLETED","sponsor":"University of Roma La Sapienza","startDate":"2012-04","conditions":"Pregnancy, Infertility, Auto-immune Thyroiditis","enrollment":56},{"nctId":"NCT02920385","phase":"PHASE1","title":"A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Levothyroxine and the Influence of Co-administered Tablets on the Pharmacokinetics of Semaglutide Administered Orally in Healthy Subjects.","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2016-10-10","conditions":"Diabetes, Healthy","enrollment":45},{"nctId":"NCT03173742","phase":"PHASE1","title":"Bioavailability and Safety of Two Oral Fixed Dose Preparations Containing 18 mg Ivermectin (IVM 18 MG TABLETS, LICONSA S.A., Spain) Versus Reference Dosing (Weight Based) Containing 6 mg Ivermectin (REVECTINA®, Abbott Laboratórios do Brasil Ltda, Brazil)","status":"COMPLETED","sponsor":"Insud Pharma","startDate":"2016-03","conditions":"Helminthiasis","enrollment":54},{"nctId":"NCT00230802","phase":"NA","title":"Thyroid Hormone Dose Adjustment in Pregnancy","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2005-07","conditions":"Pregnancy, Hypothyroidism","enrollment":48},{"nctId":"NCT02917863","phase":"PHASE4","title":"Randomized Crossover Trial for the Evaluation of the Possible Effects in the Intestine of Two Different Pharmaceutical Forms of L - Thyroxine in Patients With Primary Acquired Hypothyroidism","status":"UNKNOWN","sponsor":"Meyer Children's Hospital IRCCS","startDate":"2016-05","conditions":"Hypothyroidism","enrollment":70},{"nctId":"NCT01436994","phase":"PHASE3","title":"Antithyroid Drug Treatment of Thyrotoxicosis in Young People","status":"COMPLETED","sponsor":"Newcastle-upon-Tyne Hospitals NHS Trust","startDate":"2004-07","conditions":"Paediatric Thyrotoxicosis","enrollment":81},{"nctId":"NCT02711943","phase":"","title":"Non Interventional Study of Levofloxacin in Chronic Prostatitis","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2013-07","conditions":"Chronic Prostatitis","enrollment":500},{"nctId":"NCT02570581","phase":"PHASE1","title":"MELA Study - Hedonic Study on the Taste of Drugs Crushed in Food: Observational Study Involving 16 Healthy Volunteers","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nice","startDate":"2014-06","conditions":"Healthy","enrollment":16},{"nctId":"NCT01916304","phase":"PHASE2","title":"Study of Dose Adjustment From Levothyroxine to a New Levothyroxine Sodium Test Formulation","status":"COMPLETED","sponsor":"Takeda","startDate":"2013-07","conditions":"Hypothyroidism","enrollment":101},{"nctId":"NCT02395913","phase":"PHASE1","title":"Compare Safety and Pharmacokinetic Properties of Surfolase Capsule(Acebrophylline 100mg) and Surfolase CR(200mg)","status":"COMPLETED","sponsor":"Hyundai Pharmaceutical Co., LTD.","startDate":"2013-07","conditions":"Healthy Male","enrollment":72},{"nctId":"NCT01769157","phase":"PHASE4","title":"Effects of L-carnitine on Hypothyroidism","status":"COMPLETED","sponsor":"Korea University Anam Hospital","startDate":"2012-08","conditions":"Hypothyroidism","enrollment":60},{"nctId":"NCT01536678","phase":"PHASE4","title":"Bioequivalence of Two Levothyroxine Tablet Formulations in Healthy Indian Volunteers","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2012-01","conditions":"Hypothyroidism","enrollment":26},{"nctId":"NCT00535561","phase":"PHASE1","title":"Iron Deficiency Anemia Can be an Indication for Treatment of Subclinical Hypothyroidism","status":"COMPLETED","sponsor":"Duzce University","startDate":"2007-06","conditions":"Iron Deficiency Anemia, Subclinical Hypothyroidism","enrollment":""},{"nctId":"NCT01486667","phase":"PHASE3","title":"Thyroxin Treatment in Sub Clinical Hypothyroidism, on the Apnea Hypopnea Index Score, Lipids and Highly Sensitive CRP","status":"UNKNOWN","sponsor":"King Saud University","startDate":"2011-10","conditions":"Dyslipidemia","enrollment":200},{"nctId":"NCT01465646","phase":"PHASE1","title":"Bioavailability Investigations of Thyronajod Mite Tablets of Dosage Strengths 50 μg Levothyrox-ine/75 μg Iodine, and 100 μg Levothyroxine/75 μg Iodine vs. a Levothyroxine Drinking-Solution: A Randomised Cross Over Study in Healthy Male Individuals. Currently: 100 μg/ 75 μg Tablets","status":"COMPLETED","sponsor":"Heidelberg University","startDate":"2003-06","conditions":"Pharmacokinetics","enrollment":24},{"nctId":"NCT01465633","phase":"PHASE1","title":"Bioavailability Investigations of Thyronajod Mite Tablets of Dosage Strengths 50 μg Levothyrox-ine/75 μg Iodine, and 100 μg Levothyroxine/75 μg Iodine vs. a Levothyroxine Drinking-Solution: A Randomised Cross Over Study in Healthy Male Individuals. Currently: 50 μg/ 75 μg Tablets","status":"COMPLETED","sponsor":"Heidelberg University","startDate":"2003-08","conditions":"Pharmacokinetics","enrollment":24},{"nctId":"NCT00277589","phase":"PHASE4","title":"LISA-study : Levothyroxin in Nodular Goiter","status":"COMPLETED","sponsor":"Sanofi","startDate":"2004-05","conditions":"Goiter, Nodular","enrollment":1024}],"_emaApprovals":[],"_faersSignals":[{"count":13,"reaction":"FATIGUE"},{"count":10,"reaction":"NAUSEA"},{"count":7,"reaction":"HEADACHE"},{"count":7,"reaction":"OFF LABEL USE"},{"count":6,"reaction":"DRUG INEFFECTIVE"},{"count":6,"reaction":"MALAISE"},{"count":5,"reaction":"PAIN"},{"count":5,"reaction":"RASH"},{"count":4,"reaction":"ARTHRALGIA"},{"count":4,"reaction":"ASTHENIA"}],"_approvalHistory":[],"publicationCount":21,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Tirosint"],"phase":"marketed","status":"active","brandName":"Levothyroxine Tablet","genericName":"Levothyroxine Tablet","companyName":"University of California, Los Angeles","companyId":"university-of-california-los-angeles","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Levothyroxine is a synthetic thyroid hormone that replaces or supplements endogenous thyroid hormone to restore normal metabolic function. Used for Hypothyroidism, Thyroid cancer suppression therapy, Myxedema coma.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}